价格

CART-EGFR

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

靶向mesothelin的嵌合抗原受体并对其双重修饰的方法和用途
CN 108624607 B申请人: 上海恒润达生生物科技股份有限公司优先权: 2017
CN
靶向mesothelin的第四代嵌合抗原受体的制备方法和用途
CN 108624608 B申请人: 上海恒润达生生物科技股份有限公司优先权: 2017
CN
EGFR SINGLE-DOMAIN ANTIBODY CART FOR TREATING TUMOR AND APPLICATION THEREOF
CN 109996872 A申请人: PREGENE BIOPHARMA COMPANY SHENZHEN优先权: 2017
CN
Method and application of chimeric antigen receptor targeting humanized mesothelin
CN 109504696 A申请人: SHANGHAI HRAIN BIOTECHNOLOGY CO LTD优先权: 2017
CN
Preparation method and application of chimeric antigen receptor targeting humanized mesothelin
- CN 109504697 A
  申请人: SHANGHAI HRAIN BIOTECHNOLOGY CO LTD优先权: 2017
  CN
- CN 108715616 A
  申请人: SHANGHAI HENGRUN DASHENG BIOTECHNOLOGY CO LTD优先权: 2018
  CN
一种靶向全人源化mesothelin的嵌合抗原受体的方法和用途
CN 109504698 B申请人: 上海恒润达生生物科技股份有限公司优先权: 2017
CN
Transgenic T cell of targeted CD19 antigen as well as preparation method and application of transgenic T cell
CN 107759700 A申请人: YINFENG BIOLOGICAL GROUP LTD优先权: 2017
CN
Transgenic T cell of targeted CD30 antigen as well as preparation method and application of transgenic T cell
CN 107759699 A申请人: YINFENG BIOLOGICAL GROUP LTD优先权: 2017
CN
Myeloma BCMA antigen-targeted transgenic T cell, and preparation method and application thereof
CN 107827989 A申请人: YINFENG BIOLOGICAL GROUP CO LTD优先权: 2017
CN
Chimeric antigen receptor targeting mesothelin and CD19 double target points, method and applications thereof
CN 110724698 A申请人: SHANGHAI HRAIN BIOTECHNOLOGY CO LTD优先权: 2018
CN

药物

CART-EGFR

专利

Preparation method and application of chimeric antigen receptor targeting humanized mesothelin